Screener
Tarsus Pharmaceuticals, Inc. TARS Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:25 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001819790-26-000064
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Interest expense | (2,156) | (2,240) | (4,284) | (4,453) |
| Gain on exchange of long-term investments | 2,812 | — | 2,812 | — |
| Other income (expense), net | (281) | (145) | (368) | (226) |
| Total other income (expense), net | 4,073 | 1,844 | 5,580 | 3,004 |
| Provision for income taxes | (2,716) | — | (5,068) | — |
| Net loss | $(18,551) | $(20,340) | $(25,518) | $(45,460) |
| Unrealized gain (loss) on marketable securities and cash equivalents | (259) | (46) | (938) | (140) |
| Comprehensive loss | $(18,810) | $(20,386) | $(26,456) | $(45,600) |
Item 1. Financial Statements
FAQ
- What is Tarsus Pharmaceuticals, Inc.'s other income (expense)?
- Tarsus Pharmaceuticals, Inc. (TARS) reported other income (expense) of $4.07M in Q2 2026.
- How has Tarsus Pharmaceuticals, Inc.'s other income (expense) changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s other income (expense) increased by 120.9% year-over-year, from $1.84M to $4.07M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s other income (expense)?
- Over 4 years (2021 to 2025), Tarsus Pharmaceuticals, Inc.'s other income (expense) has grown at a 42.2% compound annual growth rate (CAGR), from -$1.62M to $6.61M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Tarsus Pharmaceuticals, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude